Markets:

Overview

News

Currencies

International

Treasuries

Anebulo Pharmaceuticals, Inc. - Common Stock (NQ:ANEB)

0.4611 -0.0204 (-4.24%)

Streaming Delayed Price Updated: 11:37 AM EST, Feb 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Anebulo Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 Next >

Deal Dispatch: Need M&A Approval? FCC Chair Explains How To Get It ↗

September 19, 2025

The "Jimmy Kimmel Live" drama coincided with reports of tit-for-tat maneuvering between the FCC and corporations desperate for deal approval.

Via Benzinga

Which stocks are gapping on Friday? ↗

September 12, 2025

Let's delve into the US markets on Friday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.

Via Chartmill

Top movers in Friday's pre-market session ↗

September 12, 2025

The US market session of Friday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Via Chartmill

Substance Use Disorder Focused Anebulo Could Be Attractive Acquisition Target, Analyst Says ↗

September 18, 2023

H.C.

Via Benzinga

Anebulo Pharmaceuticals: Q3 Earnings Insights ↗

May 11, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 12, 2025

Via Benzinga

On Thursday, there are stocks with unusual volume. Let's take a look. ↗

July 24, 2025

Discover the stocks with unexpected trading volume in today's session on the US markets.

Via Chartmill

Crude Oil Falls; Thermo Fisher Scientific Earnings Top Views ↗

July 23, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 23, 2025

Via Benzinga

Dow Surges Over 200 Points; AT&T Posts Upbeat Earnings ↗

July 23, 2025

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 23, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 27, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 13, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 26, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 24, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

June 07, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 31, 2024

Via Benzinga

ANEB Stock Earnings: Anebulo Pharmaceuticals Beats EPS for Q3 2024 ↗

May 15, 2024

ANEB stock results show that Anebulo Pharmaceuticals beat analyst estimates for earnings per share the third quarter of 2024.

Via InvestorPlace

Substance Use Disorder Company Narrows Q2 Net Loss, Reports Progress On Cannabinoid Intoxication Drug ↗

February 14, 2024

Substance use disorder-focused biopharmaceutical company Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) reported on Tuesday second quarter financial results for the three months ended Dec. 31, 2023, The...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 21, 2023

Via Benzinga

Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

October 17, 2023

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 17, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 18, 2023 ↗

September 18, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 22, 2023

Via Benzinga

Anebulo Receives Positive Feedback From FDA On Path To Phase 3 Trial Of Its Drug For Acute Cannabinoid Intoxication ↗

August 21, 2023

Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) announced positive feedback from the United States Food and Drug Administration following a type B meeting in July.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 21, 2023

Via Benzinga

Antidote For THC? Anebulo Releases Positive Clinical Data Showing Potential Of Its Drug For Treatment Of Acute Cannabinoid Intoxication ↗

March 29, 2023

Anebulo Pharmaceuticals, Inc.

Via Benzinga

Latest Executive Changes In Marijuana Industry, New Appointments & Resignations ↗

March 13, 2023

As the Benzinga Cannabis Capital Conference returns to Miami (April 11-12), gathering top CEOs, investors and leaders in the mari

Via Benzinga

Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 07, 2023

Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announced an agreement for the distribution of an Avian Influenza A Virus real-time PCR test kit to the...

Via Benzinga

Why Heart Test Laboratories Are Trading Higher By 136%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 30, 2023

Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares surged 136% to $2.06 after Ascendant Capital initiated coverage on the stock with a Buy rating and a $3.30 price target.

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Anebulo Pharmaceuticals, Inc. - Common Stock (NQ:ANEB)

Headline News about Anebulo Pharmaceuticals, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today